TY - JOUR
T1 - Postnatal maternal depressive symptoms and behavioural outcomes in term-born and preterm-born toddlers
T2 - A longitudinal UK community cohort study
AU - Kleine, Ira
AU - Vamvakas, George
AU - Lautarescu, Alexandra
AU - Falconer, Shona
AU - Chew, Andrew
AU - Counsell, Serena
AU - Pickles, Andrew
AU - Edwards, David
AU - Nosarti, Chiara
N1 - Publisher Copyright:
©
PY - 2022/9/1
Y1 - 2022/9/1
N2 - Objectives To examine the association between maternal depressive symptoms in the immediate postnatal period and offspring's behavioural outcomes in a large cohort of term-born and preterm-born toddlers. Design and participants Data were drawn from the Developing Human Connectome Project. Maternal postnatal depressive symptoms were assessed at term-equivalent age, and children's outcomes were evaluated at a median corrected age of 18.4 months (range 17.3-24.3). Exposure and outcomes Preterm birth was defined as <37 weeks completed gestation. Maternal depressive symptoms were assessed with the Edinburgh Postnatal Depression Scale (EPDS). Toddlers' outcome measures were parent-rated Child Behaviour Checklist 1 1/2 -5 Total (CBCL) and Quantitative Checklist for Autism in Toddlers (Q-CHAT) scores. Toddlers' cognition was assessed with the Bayley Scales of Infant and Toddler Development - Third Edition (Bayley-III). Results Higher maternal EPDS scores were associated with toddlers' higher CBCL (B=0.93, 95% CI 0.43 to 1.44, p<0.001, f 2 =0.05) and Q-CHAT scores (B=0.27, 95% CI 0.03 to 0.52, p=0.031, f 2 =0.01). Maternal EPDS, toddlers' CBCL and Q-CHAT scores did not differ between preterm (n=97; 19.1% of the total sample) and term participants. Maternal EPDS score did not disproportionately affect preterm children with respect to CBCL or Q-CHAT scores. Conclusions Our findings indicate that children whose mothers reported increased depressive symptoms in the early postnatal period, including subclinical symptoms, exhibit more parent-reported behavioural problems in toddlerhood. These associations were independent of gestational age. Further research is needed to confirm the clinical significance of these findings.
AB - Objectives To examine the association between maternal depressive symptoms in the immediate postnatal period and offspring's behavioural outcomes in a large cohort of term-born and preterm-born toddlers. Design and participants Data were drawn from the Developing Human Connectome Project. Maternal postnatal depressive symptoms were assessed at term-equivalent age, and children's outcomes were evaluated at a median corrected age of 18.4 months (range 17.3-24.3). Exposure and outcomes Preterm birth was defined as <37 weeks completed gestation. Maternal depressive symptoms were assessed with the Edinburgh Postnatal Depression Scale (EPDS). Toddlers' outcome measures were parent-rated Child Behaviour Checklist 1 1/2 -5 Total (CBCL) and Quantitative Checklist for Autism in Toddlers (Q-CHAT) scores. Toddlers' cognition was assessed with the Bayley Scales of Infant and Toddler Development - Third Edition (Bayley-III). Results Higher maternal EPDS scores were associated with toddlers' higher CBCL (B=0.93, 95% CI 0.43 to 1.44, p<0.001, f 2 =0.05) and Q-CHAT scores (B=0.27, 95% CI 0.03 to 0.52, p=0.031, f 2 =0.01). Maternal EPDS, toddlers' CBCL and Q-CHAT scores did not differ between preterm (n=97; 19.1% of the total sample) and term participants. Maternal EPDS score did not disproportionately affect preterm children with respect to CBCL or Q-CHAT scores. Conclusions Our findings indicate that children whose mothers reported increased depressive symptoms in the early postnatal period, including subclinical symptoms, exhibit more parent-reported behavioural problems in toddlerhood. These associations were independent of gestational age. Further research is needed to confirm the clinical significance of these findings.
KW - Child & adolescent psychiatry
KW - Depression & mood disorders
KW - Developmental neurology & neurodisability
KW - MENTAL HEALTH
KW - NEONATOLOGY
UR - http://www.scopus.com/inward/record.url?scp=85137928030&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2021-058540
DO - 10.1136/bmjopen-2021-058540
M3 - Article
C2 - 36581974
AN - SCOPUS:85137928030
SN - 2044-6055
VL - 12
JO - BMJ Open
JF - BMJ Open
IS - 9
M1 - 058540
ER -